Current Report Filing (8-k)
April 01 2019 - 9:34AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event
Reported): April 1, 2019
OZOP SURGICAL CORP.
(Exact name of registrant as specified
in its charter
)
Nevada
|
000-55976
|
35-2540672
|
(State or Other Jurisdiction
of Incorporation)
|
(Commission File Number)
|
(I.R.S. Employer Identification Number)
|
319 Clematis Street Suite 714 West Palm
Beach FL 33401
(Address of principal executive offices,
including zip code)
(866) 286-1055
(Registrant’s telephone number,
including area code)
Not applicable.
(Former name or former address, if changed
since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
☐
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
☐
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
☐
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
☐
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
|
|
☑
|
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
|
|
|
☐
|
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
|
Item 7.01 Regulation FD Disclosure.
On April 1, 2019,
Ozop Surgical Corp. (the “Company”) posted an investor presentation on its website at https://ir.ozopsurgical.com,
a copy of which is furnished as Exhibit 99.1 hereto.
The Company will present
the investor presentation at the Spring Investor Summit in New York City on April 1
st
and 2
nd
2019, an event
aimed at connecting small and micro-cap companies with high-level, institutional and retail investors.
The information contained
in the investor presentation attached hereto as Exhibit 99.1 is being furnished and shall not be deemed filed for purposes of Section
18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of
that Section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities
Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
Item 9.01 Financial Statements
and Exhibits.
(d) Exhibits:
Exhibit
No.
|
|
Exhibit Description
|
|
|
|
99.1
|
|
March 2019 Investor Presentation (furnished herewith).
|
SIGNATURES
Pursuant to the
requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the
undersigned, hereunto duly authorized.
|
OZOP SURGICAL CORP.
|
|
|
|
|
Date: April 1, 2019
|
By:
|
/s/Barry Hollander
|
|
|
Barry Hollander
|
|
|
Chief Financial Officer
|
Ozop Energy Solutions (PK) (USOTC:OZSC)
Historical Stock Chart
From Aug 2024 to Sep 2024
Ozop Energy Solutions (PK) (USOTC:OZSC)
Historical Stock Chart
From Sep 2023 to Sep 2024